February 18, 2021 Comments Off on New patent for Astrazeneca Pharms drug LYNPARZA Posted in: Patent Added Annual Drug Patent Expirations for LYNPARZA Lynparza is a drug marketed by Astrazeneca Pharms and is included in two NDAs. It is available from one supplier. There are eleven patents…
The post New patent for Astrazeneca Pharms drug LYNPARZA appeared fi…
February 18, 2021 Comments Off on New patent expiration for Merck Sharp drug CLARINEX-D 12 HOUR Posted in: Uncategorized
Annual Drug Patent Expirations for CLARINEX-D+12+HOUR Clarinex-d 12 Hour is a drug marketed by Merck Sharp Dohme and is included in one NDA. It is available from one supplier. There…
The post New patent expiration for Merck Sharp drug CLARINEX-D 12 HOU…
